Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
The fellowship program has an outstanding reputation for attracting the best and the brightest PhDs in the sciences and for training future leaders in Climate and Global Change Science. In FY25
-
, single-cell analysis capabilities, opportunities to partner with the country's strongest concentration of computational neuroscientists and much more. Fellows also enjoy the institute's extensive portfolio
-
. McGill implements an employment equity program and encourages members of designated groups to self-identify. Persons with disabilities who anticipate needing accommodations for any part of the application
-
extraction, PCR, and molecular cloning. Minimum Qualifications Completion of a university degree in a relevant discipline or technical program and a minimum four years of related experience or an equivalent
-
degree (M.D., Ph.D. or equivalent) and must be in a research-oriented postdoctoral training program at an academic, government, or non-profit research institution. Applicants must have more than two years
-
implements an employment equity program and encourages members of designated groups to self-identify. Persons with disabilities who anticipate needing accommodations for any part of the application process may
-
assistant will be involved in are, and not limited to, the ECHO Autism BC program, the Autism Training Simulation program, the cross Canada ECHO Autism implementation project (ECHO AuDIO), and establishing a
-
independently and as a member of a research team -Effective organizational skills and attentiveness to detail -Ability to exercise tact, discretion, and confidentiality -Computer proficiency (Word, Excel
-
assay for diagnostic purposes. Qualifications: Masters Degree required. Prior knowledge in biotechnology, molecular and computational biology, is an asset. The candidate will be required to quickly work
-
, Full Professor for Computer Science at ETH Zurich, Prof. Dr. Heidi Wunderli-Allenspach, Rector at ETH Zurich (2007 to 2012) and former Full Professor for Biopharmacy at ETH Zurich, and Prof. Dr. Josef